NCT00221052
Completed
Not Applicable
Relation Between Reduction of the Inflammatory Status and Glucose Metabolism in Healthy Overweight Men
TNO1 site in 1 country20 target enrollmentJune 2005
DrugsDiclofenac
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Overweight
- Sponsor
- TNO
- Enrollment
- 20
- Locations
- 1
- Status
- Completed
- Last Updated
- 19 years ago
Overview
Brief Summary
Overweight increases the risk to develop chronic diseases including type-2 diabetes and cardiovascular disease. The low-grade inflammatory status often seen in overweight subjects is thought to play an important role in disease development.
The purpose of this study is to determine the role of inflammation on glucose metabolism and insulin resistance. In this study the effect of the anti-inflammatory treatment diclofenac on markers of inflammation and on parameters of glucose metabolism will be studied.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Body Mass Index (BMI): 25.1 - 32.0 kg/m2
- •Normal Dutch eating habits
Exclusion Criteria
- •diabetes, cardiovascular disease or hypertension
- •Not suitable to receive diclofenac treatment
- •Extreme physical activity (more than 6 hours/week)
- •Reported slimming or medically prescribed diet
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 1
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial FunctionObesityMetabolic SyndromeNCT05972564Vanderbilt University Medical Center74
Completed
Not Applicable
Inflammation and the Metabolic Syndrome in HumansMetabolic Syndrome XNCT00954824University of Pennsylvania50
Completed
Not Applicable
Study of Immune Response in Obesity and Type 2 DiabetesObesityType 2 DiabetesHealthy VolunteersNCT01907399Centre Hospitalier Universitaire Dijon101
Completed
Phase 1
SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity PilotObesityPre-diabetesNCT04907214Vanderbilt University Medical Center29
Completed
Not Applicable
Prevalence and Cardiovascular Effects of Growth Hormone Deficiency in Abdominal ObesityObesityGrowth HormoneNCT00562796Massachusetts General Hospital149